Thomas Neenan
Founder bij AbFero Pharmaceuticals, Inc.
Profiel
Thomas X.
Neenan is the founder of Sideris Pharmaceuticals, Inc. (founded in 2012) and Panbela Therapeutics, Inc. (founded in 2011).
At Sideris Pharmaceuticals, Inc., he held the title of Chief Executive & Technology Officer.
At Panbela Therapeutics, Inc., he held the title of Chief Scientific Officer from 2016 to 2022.
Dr. Neenan is also the founder of AbFero Pharmaceuticals, Inc. Dr. Neenan's former jobs include being a Director at NDFOS Co., Ltd., Vice President-New Ventures at GelTex Pharmaceuticals, Inc., Vice President-Business Operations at Genzyme Corp., Principal at Harvard University from 1985 to 1987, Vice President-Business Development at Trine Pharmaceuticals, Inc., Principal at Bell Laboratories, and Vice President-Business Development at Warwick Effect Polymers Ltd.
In terms of education, Dr. Neenan holds a doctorate degree from Harvard University, a doctorate degree from The Pennsylvania State University (conferred in 1985), and an undergraduate degree from the National University of Ireland.
Actieve functies van Thomas Neenan
| Bedrijven | Functie | Begin |
|---|---|---|
AbFero Pharmaceuticals, Inc.
 AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | Founder | - |
Eerdere bekende functies van Thomas Neenan
| Bedrijven | Functie | Einde |
|---|---|---|
| PANBELA THERAPEUTICS, INC. | Founder | 01-06-2022 |
Trine Pharmaceuticals, Inc.
 Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Corporate Officer/Principal | 19-09-2008 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-1987 |
| NDFOS CO., LTD. | Director/Board Member | - |
Sideris Pharmaceuticals, Inc.
 Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Chief Executive Officer | - |
Opleiding van Thomas Neenan
| Harvard University | Doctorate Degree |
| The Pennsylvania State University | Doctorate Degree |
| National University of Ireland | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PANBELA THERAPEUTICS, INC. | Health Technology |
| NDFOS CO., LTD. | Process Industries |
| Bedrijven in privébezit | 7 |
|---|---|
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Health Technology |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Health Technology |
Bell Laboratories
 Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Bell Laboratories provides research and development services. It provides communications technologies including transistors, digital networking, signal processing, lasers and fiber-optic communications systems, communication satellites, cellular telephony, electronic switching of calls, touch-tone dialing and modems. The company was founded in 1925 and is headquartered in Murray Hill, NJ. | Commercial Services |
Warwick Effect Polymers Ltd.
 Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | Process Industries |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | Health Technology |
